A multicenter, double-blind, placebo-controlled trial of the PDE9A inhibitor, PF-04447943, in Alzheimer's disease.
A multicenter, double-blind, placebo-controlled trial of the PDE9A inhibitor PF-04447943 in Alzheimer's disease.